This inventor holds 2 USPTO granted patents. Top assignee: Kowa Company Limited. Active years: 1987-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1988
Title: The Innovations of Touru Yokoyama: A Visionary in Pharmaceutical Science
Introduction: Touru Yokoyama is a notable inventor based in Tokyo, Japan, who has made significant contributions to the field of pharmaceutical sciences. With two patents to his name, his work showcases a commitment to developing innovative solutions for drug administration, especially regarding intestinal absorption.
Latest Patents: Among his latest patents is a groundbreaking pharmaceutical composition particularly suitable for intestinal administration. This composition includes a physiologically active substance that possesses peptide bonds but is inactivable by digestive enzymes. Importantly, the active substances utilized are distinct from insulin, alongside a synthetic chymotrypsin inhibitor. This formulation aims to enhance the intestinal absorption of the active substances, potentially revolutionizing how certain medications are delivered.
Career Highlights: Touru Yokoyama currently works with Kowa Company Limited, a well-regarded name in the pharmaceutical industry. His dedication to research and innovation has positioned him as a key figure in the development of new therapies that could drastically improve patient outcomes.
Collaborations: In his journey, Yokoyama has collaborated with notable coworkers, including Setsuro Fujii and Kouji Ikegaya. Together, they contribute to a dynamic research environment that fosters innovation, allowing for the exchange of ideas and advancements within the pharmaceutical sector.
Conclusion: Touru Yokoyama's inventive spirit and his contributions to pharmaceutical compositions not only advance science but also pave the way for enhanced drug delivery systems. As he continues to innovate at Kowa Company Limited, the impact of his work will undoubtedly resonate within the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
